A phase 2 study of de-escalation in resectable, locally advanced cutaneous squamous cell carcinoma with the use of neoadjuvant Pembrolizumab - DESQUAMATE (2022–2025)
- Grant type:
- Metro South Hospital and Health Service
- Researchers:
-
-
- Funded by:
- Metro South Hospital and Health Service
